Collectively, our findings suggest that a reduction in IL-6ST/gp130-dependent STAT3 activity results in dysregulated expression of tight junction proteins, thereby impairing barrier function to increase susceptibility to DSS-induced colitis. Here, IL6ST is linked to colitis.